Most tumors were IDH-1 wildtype, and only one patient had an IDH mutation (R132H); the latter tumor would now be (re-)classified as an astrocytoma, IDH-mutant, WHO grade 4. The gene discussed is IDH1; the disease is astrocytoma (excluding glioblastoma).